SHSE:603579

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Shanghai Rongtai Health Technology

Executive Summary

Shanghai Rongtai Health Technology Corporation Limited provides massage chairs, mini massage series products, and massage accessories in China and internationally. More Details


Snowflake Analysis

Flawless balance sheet, good value and pays a dividend.

Share Price & News

How has Shanghai Rongtai Health Technology's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: 603579 is not significantly more volatile than the rest of CN stocks over the past 3 months, typically moving +/- 5% a week.

Volatility Over Time: 603579's weekly volatility (5%) has been stable over the past year.


Market Performance


7 Day Return

-6.4%

603579

3.7%

CN Leisure

-1.3%

CN Market


1 Year Return

-15.4%

603579

13.0%

CN Leisure

25.5%

CN Market

Return vs Industry: 603579 underperformed the CN Leisure industry which returned 13% over the past year.

Return vs Market: 603579 underperformed the CN Market which returned 25.5% over the past year.


Shareholder returns

603579IndustryMarket
7 Day-6.4%3.7%-1.3%
30 Day-12.0%0.3%5.4%
90 Day-15.4%-6.3%5.8%
1 Year-11.0%-15.4%14.1%13.0%27.6%25.5%
3 Year-60.5%-63.4%1.2%-1.2%23.6%17.5%
5 Yearn/a-58.6%-59.5%39.6%30.2%

Long-Term Price Volatility Vs. Market

How volatile is Shanghai Rongtai Health Technology's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Shanghai Rongtai Health Technology undervalued compared to its fair value and its price relative to the market?

15.67x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Below Fair Value: 603579 (CN¥28.25) is trading above our estimate of fair value (CN¥4.18)

Significantly Below Fair Value: 603579 is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: 603579 is good value based on its PE Ratio (15.7x) compared to the CN Leisure industry average (28.4x).

PE vs Market: 603579 is good value based on its PE Ratio (15.7x) compared to the CN market (35x).


Price to Earnings Growth Ratio

PEG Ratio: 603579 is good value based on its PEG Ratio (0.8x)


Price to Book Ratio

PB vs Industry: 603579 is good value based on its PB Ratio (2.4x) compared to the CN Leisure industry average (2.7x).


Next Steps

Future Growth

How is Shanghai Rongtai Health Technology forecast to perform in the next 1 to 3 years based on estimates from 3 analysts?

20.0%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: 603579's forecast earnings growth (20% per year) is above the savings rate (3.3%).

Earnings vs Market: 603579's earnings (20% per year) are forecast to grow slower than the CN market (24.2% per year).

High Growth Earnings: earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 603579's revenue (15.7% per year) is forecast to grow slower than the CN market (18.1% per year).

High Growth Revenue: 603579's revenue (15.7% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: 603579's Return on Equity is forecast to be low in 3 years time (16.9%).


Next Steps

  • Explore growth companies in the Consumer Durables industry.

Past Performance

How has Shanghai Rongtai Health Technology performed over the past 5 years?

9.3%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: 603579 has high quality earnings.

Growing Profit Margin: 603579's current net profit margins (11.8%) are lower than last year (12.7%).


Past Earnings Growth Analysis

Earnings Trend: 603579's earnings have grown by 9.3% per year over the past 5 years.

Accelerating Growth: 603579's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 603579 had negative earnings growth (-10.3%) over the past year, making it difficult to compare to the Leisure industry average (23.8%).


Return on Equity

High ROE: 603579's Return on Equity (14.7%) is considered low.


Next Steps

Financial Health

How is Shanghai Rongtai Health Technology's financial position?


Financial Position Analysis

Short Term Liabilities: 603579's short term assets (CN¥1.3B) exceed its short term liabilities (CN¥629.3M).

Long Term Liabilities: 603579's short term assets (CN¥1.3B) exceed its long term liabilities (CN¥18.9M).


Debt to Equity History and Analysis

Debt Level: 603579 is debt free.

Reducing Debt: 603579 has no debt compared to 5 years ago when its debt to equity ratio was 5.7%.

Debt Coverage: 603579 has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: 603579 has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet


Next Steps

Dividend

What is Shanghai Rongtai Health Technology current dividend yield, its reliability and sustainability?

5.31%

Current Dividend Yield


Dividend Yield vs Market

Notable Dividend: 603579's dividend (5.31%) is higher than the bottom 25% of dividend payers in the CN market (0.4%).

High Dividend: 603579's dividend (5.31%) is in the top 25% of dividend payers in the CN market (1.81%)


Stability and Growth of Payments

Stable Dividend: 603579 has been paying a dividend for less than 10 years and during this time payments have been volatile.

Growing Dividend: 603579's dividend payments have increased, but the company has only paid a dividend for 4 years.


Current Payout to Shareholders

Dividend Coverage: At its current payout ratio (83.2%), 603579's payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: 603579's dividends in 3 years are forecast to be thoroughly covered by earnings (3.9% payout ratio).


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?


CEO

Shanghai Rongtai Health Technology has no CEO, or we have no data on them.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Shanghai Rongtai Health Technology Corporation Limited's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Shanghai Rongtai Health Technology Corporation Limited
  • Ticker: 603579
  • Exchange: SHSE
  • Founded: 1997
  • Industry: Leisure Products
  • Sector: Consumer Durables
  • Market Cap: CN¥3.852b
  • Shares outstanding: 136.37m
  • Website: https://www.aront.cn

Number of Employees


Location

  • Shanghai Rongtai Health Technology Corporation Limited
  • NO.1226 Zhufeng Road
  • Qingpu District
  • Shanghai
  • 201714
  • China

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
603579SHSE (Shanghai Stock Exchange)YesDomestic SharesCNCNYJan 2017
603579XSSC (Shanghai Stock Exchange - Shanghai - Hong Kong Stock Connect)YesDomestic SharesCNCNYJan 2017

Biography

Shanghai Rongtai Health Technology Corporation Limited provides massage chairs, mini massage series products, and massage accessories in China and internationally. The company was founded in 1997 and is ba...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/01/16 09:28
End of Day Share Price2021/01/15 00:00
Earnings2020/09/30
Annual Earnings2019/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.